There have been researches indicating that 18 F-FDG PET may non-invasively predict tumor response to treatment and reflect biologic aggressiveness of tumor such as cell viability, proliferative activity, hypoxia, low apoptosis rate, and P53 over-expression in head and neck tumors [25]. This evidence concerns the gene TP53 and neoplasm.